Home > Drugs A-Z > FIBERCON

FIBERCON (Wyeth Pharmaceutical Division of Wyeth Holdings Corporation, a subsidiary of Pfizer Inc.)

Available Formats

Dosage Form Package Information Links
TABLET 140 TABLET in 1 BOTTLE (0005-2500-23) Label Information
TABLET 9 BLISTER PACK in 1 CARTON (0005-2500-02) > 4 TABLET in 1 BLISTER PACK Label Information
TABLET 1 BOTTLE in 1 CARTON (0005-2500-33) > 90 TABLET in 1 BOTTLE Label Information

Complete FIBERCON Information

  • SPL UNCLASSIFIED SECTION

    Drug Facts


  • ACTIVE INGREDIENT

    Active ingredient (in each caplet) Purpose
    Calcium polycarbophil 625 mg equivalent to 500 mg polycarbophil Bulk-forming laxative

  • INDICATIONS & USAGE

    Uses

    • relieves occasional constipation to help restore and maintain regularity
    • this product generally produces bowel movement in 12 to 72 hours

  • WARNINGS

    Warnings

    Choking:

    Taking this product without adequate fluid may cause it to swell and block your throat or esophagus and may cause choking. Do not take this product if you have difficulty in swallowing. If you experience chest pain, vomiting, or difficulty in swallowing or breathing after taking this product, seek immediate medical attention.

    Ask a doctor before use if you have
    • abdominal pain, nausea, or vomiting
    • a sudden change in bowel habits that persists over a period of 2 weeks

    Ask a doctor or pharmacist before use if you are

    taking any other drug. Take this product 2 or more hours before or after other drugs. All laxatives may affect how other drugs work.

    When using this product
    • do not use for more than 7 days unless directed by a doctor
    • do not take more than 8 caplets in a 24 hour period unless directed by a doctor

    Stop use and ask a doctor if

    rectal bleeding occurs or if you fail to have a bowel movement after use of this or any other laxative. These could be signs of a serious condition.

    Keep out of reach of children.

    In case of overdose, get medical help or contact a Poison Control Center right away.


  • DOSAGE & ADMINISTRATION

    Directions

    • take each dose of this product with at least 8 ounces (a full glass) of water or other fluid. Taking this product without enough liquid may cause choking. See choking warning.
    • FiberCon works naturally so continued use for one to three days is normally required to provide full benefit. Dosage may vary according to diet, exercise, previous laxative use or severity of constipation.
    age recommended dose daily maximum
    adults and children 12 years of age and over 2 caplets once a day up to 4 times a day
    children under 12 years consult a physician  

  • SPL UNCLASSIFIED SECTION

    Other information

    • each caplet contains: 140 mg calcium and 10 mg magnesium
    • protect contents from moisture
    • store at 20-25°C (68-77°F)

  • INACTIVE INGREDIENT

    Inactive ingredients

    caramel, crospovidone, hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, silicon dioxide, sodium lauryl sulfate


  • QUESTIONS

    Questions or comments?

    Call weekdays from 9 AM to 5 PM EST at 1-800-282-8805


  • PRINCIPAL DISPLAY PANEL - 36 Caplet Blister Pack Carton

    FiberCon®

    Calcium Polycarbophil Bulk-Forming Laxative

    Fiber Therapy for Regularity


    • Gentle Enough for
      Everyday Use*
    • Won't Ferment to
      Cause Gas or Bloating
    • As Effective as
      Fiber Powders

    *when used as directed

    CONVENIENT
    TRAVEL PACK!

    36 Caplets

    Principal Display Panel - 36 Caplet Blister Pack Carton

  • INGREDIENTS AND APPEARANCE
    FIBERCON 
    calcium polycarbophil tablet
    Product Information
    Product Type HUMAN OTC DRUG Item Code (Source) NDC:0005-2500
    Route of Administration ORAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    CALCIUM POLYCARBOPHIL (UNII: 8F049NKY49) (POLYCARBOPHIL - UNII:W25LM17A4W) CALCIUM POLYCARBOPHIL 625 mg
    Inactive Ingredients
    Ingredient Name Strength
    CARAMEL (UNII: T9D99G2B1R)  
    CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  
    CROSPOVIDONE (UNII: 68401960MK)  
    HYPROMELLOSES (UNII: 3NXW29V3WO)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    POLYETHYLENE GLYCOLS (UNII: 3WJQ0SDW1A)  
    SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
    SODIUM LAURYL SULFATE (UNII: 368GB5141J)  
    Product Characteristics
    Color GRAY (Off white to grayish color depending on lighting) Score no score
    Shape OVAL Size 20mm
    Flavor Imprint Code
    Contains     
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:0005-2500-02 9 in 1 CARTON
    1 4 in 1 BLISTER PACK
    2 NDC:0005-2500-33 1 in 1 CARTON
    2 90 in 1 BOTTLE
    3 NDC:0005-2500-23 140 in 1 BOTTLE
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    OTC MONOGRAPH NOT FINAL part334 01/05/2004
    Labeler - Wyeth Pharmaceutical Division of Wyeth Holdings Corporation, a subsidiary of Pfizer Inc. (054065909)